Biomarker insights

· 2 papers in corpus
2026
doi:10.1177/11772719261438618 ·PMID:41971711

The increasing mortality from ovarian and lung cancers worldwide is largely due to late diagnosis and therapeutic resistance. Conventional biomarkers such as CA125 and CYFRA 21-1 lack the sensitivity or the specificity for monitoring real t…

2023
doi:10.1177/11772719231210407 ·PMID:38035182

BackgroundDeregulation in the urokinase-type plasminogen activator receptor (uPA/uPAR) system is reported in many diseases where the immune system is activated. During SARS-CoV-2 infection, a rise in soluble uPAR (suPAR) levels has been det…